Newsletter

Subscribe and recieve updates on this company.

Text STOCKS to 72727 for mobile alerts

We are excited to present CohBar Inc. (NASDAQ: CWBR).

Full DD Report for CWBR

You must become a subscriber to view this report.


Recent News from (NASDAQ: CWBR)

3 Young Biotechs Positioned To Upend Medicine
Introduction The following three stocks are biotechnology companies that could upend medicine as we know it. The therapeutics they are developing are novel and could be revolutionary. While we recommend buying shares in these stocks, at the prices listed, for a long-term hold, they may not p...
Source: SeekingAlpha
Date: May, 17 2018 10:51
CohBar reports Q1 results
CohBar (NASDAQ: CWBR ): Q1 EPS of -$0.09 Cash, cash equivalents and investments of of $8.46M Press Release More news on: CohBar Inc., Earnings news and commentary, Healthcare stocks news, ,
Source: SeekingAlpha
Date: May, 15 2018 16:30
CohBar, Inc. Announces First Quarter 2018 Financial Results
MENLO PARK, Calif., May 15, 2018 (GLOBE NEWSWIRE) -- CohBar, Inc. (NASDAQ:CWBR) (“CohBar” or the “Company”), an innovative biotechnology company developing mitochondria based therapeutics (MBTs) to treat age-related diseases, today reported its financial results ...
Source: GlobeNewswire
Date: May, 15 2018 16:03
Lucky Seven: Omeros Moves, Array Biopharma May Be Next
iShares Nasdaq Biotechnology ETF ( IBB ) was good for a 0.3% gain within the last three trading days, while the Lucky Seven netted a 2.6% gain. The Lucky Seven portfolio assumes an investor made a $1000 investment, to begin, in each pick. So, the portfolio began with $7,000. Lucky Seven ...
Source: SeekingAlpha
Date: May, 08 2018 15:02
CohBar, Inc. Announces Voluntary Delisting from the TSX Venture Exchange
MENLO PARK, Calif., April 18, 2018 (GLOBE NEWSWIRE) -- CohBar, Inc. (NASDAQ:CWBR) and (TSXV:COB.U) (“CohBar” or the “Company”) today announced that it has applied to voluntarily delist its common shares from the TSX Venture Exchange (“TSXV”).  ...
Source: GlobeNewswire
Date: April, 18 2018 16:05
CohBar, Inc. Announces Closing of Private Placement for Aggregate Gross Proceeds of Approximately $3,900,000
MENLO PARK, Calif., April 13, 2018 (GLOBE NEWSWIRE) -- CohBar, Inc. (NASDAQ:CWBR) (TSX-V:COB.U) (“CohBar” or the “Company”) is pleased to announce the closing of its second and final tranche of the previously announced private placement (the “Private Place...
Source: GlobeNewswire
Date: April, 13 2018 16:05
CohBar, Inc. Announces Fourth Quarter 2017 Financial Results
MENLO PARK, Calif., April 02, 2018 (GLOBE NEWSWIRE) -- CohBar, Inc. (NASDAQ:CWBR) (TSXV:COB.U) (“CohBar” or the “Company”), an innovative biotechnology company developing mitochondria based therapeutics (MBTs) to treat age-related diseases, today reported its fin...
Source: GlobeNewswire
Date: April, 02 2018 16:03
CohBar, Inc. Announces Closing of First Tranche of Private Placement
MENLO PARK, Calif., March 29, 2018 (GLOBE NEWSWIRE) -- CohBar, Inc. (NASDAQ:CWBR) (TSXV:COB.U) (“CohBar” or the “Company”) is pleased to announce the closing of its first tranche of its previously announced private placement (the “Private Placement”...
Source: GlobeNewswire
Date: March, 29 2018 16:10
CohBar, Inc. Announces Financing of up to US$5,000,000 in Unsecured Promissory Notes
MENLO PARK, Calif., March 26, 2018 (GLOBE NEWSWIRE) -- CohBar, Inc. (NASDAQ:CWBR) and (TSXV:COB.U) (“CohBar” or the “Company”), a preclinical stage biotechnology company developing mitochondria based therapeutics to treat age-related diseases, announced today a p...
Source: GlobeNewswire
Date: March, 26 2018 09:00
CohBar, Inc. to Announce 2017 Fourth Quarter Financial Results and Host Conference Call for Shareholders on April 2, 2018
MENLO PARK, Calif., March 19, 2018 (GLOBE NEWSWIRE) -- CohBar, Inc. (NASDAQ:CWBR) (TSXV:COB.U), an innovative biotechnology company developing mitochondria based therapeutics (MBTs) to treat age-related diseases, announced today that the Company will release its fourth quarter 2017 fin...
Source: GlobeNewswire
Date: March, 19 2018 16:35

 


Last 5 Days Trading Activity

DateOpen PriceClose PriceHighLowVolume
2018-05-185.985.905.985.804927,416
2018-05-175.985.905.985.804927,416

Last 5 Days Short Activity

DateShort VolumeTotal VolumeShort PercentageShort Indicator
2018-08-1720,17433,73059.8103Short
2018-08-1611,93749,21924.2528Cover
2018-08-1525,23196,13626.2451Cover
2018-08-1413,12039,67033.0729Cover
2018-08-1344,47777,65657.2744Short

* Cover Mode

Short Analysis provided by Squeeze Report. Get a complete short report on CWBR.


About CohBar Inc. (NASDAQ: CWBR)

Logo for CohBar Inc. (NASDAQ: CWBR)

CohBar, Inc. OTCQX: CWBR and TSXV: COB.U is an innovative biotechnology company focused on the research and development of mitochondria based therapeutics MBTs , an emerging class of drugs for the treatment of age related diseases. MBTs originate from the discovery by CohBar s founders of a novel group of peptides within the mitochondrial genome which regulate metabolism and cell death, and whose biological activity declines with age. CohBar s efforts focus on the development of these mitochondrial derived peptides MDPs into clinically relevant MBTs that offer the potential to address a broad range of age related diseases, including NASH, obesity, type diabetes, cancer, cardiovascular and neurodegenerative diseases. To date, the Company and its founders have discovered more than MDPs.

 

Contact Information

 

 

Current Management

  • Simon J. Allen / CEO
  • Jon L. Stern / COO
  • Jeffrey F. Biunno / CFO, Secretary, Treasurer
  • Kenneth Cundy / CSO
  • Abion J. Fitzgerald / Chairman, Independent Director, Audit Committee Member, Compensation Committee Member, Nominating Committee Member
  • John Amatruda /
  • Nir Barzilai / Audit Committee Member
  • Pinchas Cohen / Nominating Committee Member
  • Marc E. Goldberg / Independent Director, Audit Committee Member, Compensation Committee Member, Nominating Committee Member
  • Jon L. Stern /

Current Share Structure

  • Market Cap: $206,181,438 - 03/15/2018
  • Authorized: 75,000,000 - 01/05/2015
  • Issue and Outstanding: 39,422,837 - 11/15/2017
  • Float: 24,134,745 - 09/30/2017

 


Recent Filings from (NASDAQ: CWBR)

Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: May, 15 2018
Quarterly report with a continuing view of a company's financial position
Filing Type: 10-QFiling Source: edgar
Filing Date: May, 15 2018
Prospectus filed under Rule 424(b)(3)
Filing Type: 424B3Filing Source: edgar
Filing Date: May, 11 2018
Prospectus filed under Rule 424(b)(3)
Filing Type: 424B3Filing Source: edgar
Filing Date: May, 11 2018
Post-effective amendment to an S-Type filing
Filing Type: POS AMFiling Source: edgar
Filing Date: May, 04 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: May, 04 2018
Post-effective amendment to an S-Type filing
Filing Type: POS AMFiling Source: edgar
Filing Date: May, 04 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: May, 04 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: April, 30 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: April, 30 2018

 

 


Daily Technical Chart for (NASDAQ: CWBR)

Daily Technical Chart for (NASDAQ: CWBR)


Stay tuned for daily updates and more on (NASDAQ: CWBR)

It most certainly could but even more important is the recent overwhelming interest in the company. Check out Investors Hub and search on Twitter

More to come on (NASDAQ: CWBR)

Do your DD and if you choose, be ready to go!


 

The Research: All source information contained in this email is from the public sources mentioned below.

 

 
 

Thank you

DD Report
@DDReports

 

 


Disclaimer: DD Report publishes reports providing information on selected companies. DD Report is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. DD Report accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in CWBR is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. DD Report has received up to $100,000 worth of crypto currency from a non-affiliated third party for the publication and circulation of this report. DD Report does not own any shares of CWBR and does not buy, sell, or trade any shares of CWBR. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2018 by DD Report. All rights reserved. Our Full Disclaimer: http://dd.report/disclaimer/